Raynaud phenomenon and digital ulcers in systemic sclerosis

被引:0
|
作者
Michael Hughes
Yannick Allanore
Lorinda Chung
John D. Pauling
Christopher P. Denton
Marco Matucci-Cerinic
机构
[1] Royal Hallamshire Hospital,Department of Rheumatology
[2] Sheffield Teaching Hospitals NHS Foundation Trust,Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health
[3] The University of Manchester,Department of Rheumatology
[4] Cochin Hospital,Division of Immunology and Rheumatology, Department of Medicine
[5] AP-HP,Department of Pharmacy and Pharmacology
[6] Paris Descartes University,Department of Rheumatology
[7] Stanford University School of Medicine and Palo Alto VA Health Care System,Division of Rheumatology
[8] University of Bath,undefined
[9] Royal National Hospital for Rheumatic Diseases (part of Royal United Hospitals Bath NHS Foundation Trust),undefined
[10] Royal Free Hospital,undefined
[11] University College London,undefined
[12] University of Florence,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Raynaud phenomenon is a symptom complex caused by impaired digital perfusion and can occur as a primary phenomenon or secondary to a wide range of underlying causes. Raynaud phenomenon occurs in virtually all patients with systemic sclerosis (SSc) and is often the earliest clinical manifestation to occur. Careful assessment is required in patients with Raynaud phenomenon to avoid missing secondary causes such as SSc. Digital ulcers are a painful and disabling visible manifestation of digital vascular injury in patients with SSc. Progress has been made in the classification and assessment of digital ulcers and in understanding ulcer pathogenesis, and there are a wide range of treatments available to both prevent and heal digital ulcers, some of which are also used in Raynaud phenomenon management. In this Review, the assessment of patients with Raynaud phenomenon is discussed, including ‘red flags’ that are suggestive of SSc. The pathogenesis, classification and assessment of SSc-associated digital ulcers are also covered, alongside an overview of management approaches for SSc-associated Raynaud phenomenon and digital ulcers. Finally, unmet needs are discussed and the concept of a unified vascular phenotype in which therapies that affect the vasculature to support disease modification strategies is introduced.
引用
收藏
页码:208 / 221
页数:13
相关论文
共 50 条
  • [41] HOW TO TREAT RAYNAUD'S PHENOMENON & SYSTEMIC SCLEROSIS?
    Riemekasten, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 4 - 4
  • [42] BOSENTAN FOR THE TREATMENT OF ISCHEMIC DIGITAL ULCERS AND RAYNAUD'S PHENOMENON
    Nitsche, Alejandro
    Crow, Catherine E.
    Asnal, Cecilia A.
    Amitrano, Cristina
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S51 - S51
  • [43] Raynaud's phenomenon and digital ulcers: advances in evaluation and management
    Herrick, Ariane L.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (06) : 453 - 462
  • [44] TREATMENT OF RAYNAUD PHENOMENON IN PROGRESSIVE SYSTEMIC-SCLEROSIS
    GIORDANO, M
    VALENTINI, G
    VATTI, M
    TIRRI, G
    CAPELLI, L
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1986, 45 (02): : 90 - 90
  • [45] Therapeutic Plasma Exchange for the Treatment of Raynaud's and Digital Ulcers in Systemic Sclerosis: A Systematic Review
    Harris, Edward S.
    Meiselman, Herbert J.
    Moriarty, Patrick M.
    Metzger, Allan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [46] Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases
    Costa, E.
    Cunha-Santos, F.
    Dourado, E.
    Oliveira, D.
    Falzon, L.
    Romao, V. C.
    Duarte, A. C.
    Cordeiro, A.
    Santiago, T.
    Sepriano, A.
    [J]. ARP RHEUMATOLOGY, 2024, 3 (02):
  • [47] Identifying Core Domains for Clinical Trials in Systemic Sclerosis-Associated Raynaud's Phenomenon and Digital Ulcers Using the Delphi Consensus Method
    Proudman, Susanna
    Hughes, Michael
    Maltez, Nancy
    Brown, Edith
    Hickey, Virginia
    Grosskleg, Shawna
    Shea, B.
    Herrick, Ariane
    Pauling, John
    Merkel, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2998 - 2999
  • [48] Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020
    Maltez, Nancy
    Hughes, Michael
    Brown, Edith
    Hickey, Virginia
    Park, Heiyoung
    Shea, Beverley
    Herrick, Ariane L.
    Pauling, John D.
    Proudman, Susanna
    Merkel, Peter A.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (03) : 640 - 643
  • [49] Long-term efficacy and safety of bosentan in the treatment of ischemic digital ulcers due to severe Raynaud's phenomenon in patients with systemic sclerosis
    Alegre-Sancho, JJ
    Fernández-Llanio, N
    Hortal-Alonso, R
    Muñoz-Gil, S
    Pareja-Lázaro, MA
    Román-Ivorra, JA
    Abad-Franch, L
    Alcañiz-Escandell, C
    Chalmeta-Verdejo, C
    Fernández-Carballido, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 287 - 287
  • [50] Audiovestibular Manifestations in Patients with Primary Raynaud's Phenomenon and Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Carlos Amor-Dorado, Juan
    Martin-Sanz, Eduardo
    Franco-Gutierrez, Virginia
    Urruticoechea-Arana, Ana
    Garcia-Arumi, Ana M.
    Racines-Alava, Erwin
    Aleman-Lopez, Oscar
    Simeon-Aznar, Carmen P.
    Gonzalez-Gay, Miguel A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)